Newbridge Financial Services Group’s Idexx Laboratories IDXX Stock Holding History

Newbridge Financial Services Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.84K	Hold	13	–	–	﹤0.01%	911
2026 Q1	$7.3K	Hold	13	–	–	﹤0.01%	847
2025 Q4	$8.79K	Sell	13 -171	-93%	-$116K	﹤0.01%	801
2025 Q3	$118K	Buy	184 +171	+1,315%	+$104K	0.02%	367
2025 Q2	$6.97K	Hold	13	–	–	﹤0.01%	968
2025 Q1	$5.46K	Sell	13 -25	-66%	-$10.9K	﹤0.01%	786
2024 Q4	$15.7K	Buy	38 +13	+52%	+$5.7K	﹤0.01%	653
2024 Q3	$12.6K	Hold	25	–	–	﹤0.01%	411
2024 Q2	$12.2K	Sell	25 -10	-29%	-$5.02K	﹤0.01%	671
2024 Q1	$18.9K	Hold	35	–	–	0.01%	615
2023 Q4	$19.4K	Hold	35	–	–	0.01%	599
2023 Q3	$15.3K	Hold	35	–	–	0.01%	709
2023 Q2	$17.6K	Hold	35	–	–	0.01%	729
2023 Q1	$17.5K	Buy	35 +10	+40%	+$4.79K	0.01%	772
2022 Q4	$10.2K	Hold	25	–	–	0.01%	913
2022 Q3	$8K	Buy	+25	New	+$9.18K	﹤0.01%	938

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Newbridge Financial Services Group's IDXX Position: Q2 2026 in Review

Newbridge Financial Services Group held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 13 shares worth $6.84K. The position accounts for ﹤0.01% of the portfolio, ranked #911.

Newbridge Financial Services Group first reported a position in IDXX in Q3 2022 and has held it in 16 quarters since. The position peaked at $118K in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Newbridge Financial Services Group held 13 shares of Idexx Laboratories worth $6.84K as of Q2 2026.
Newbridge Financial Services Group left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #911 holding.
Newbridge Financial Services Group first reported a position in Idexx Laboratories in Q3 2022 and has held it in 16 quarters since.
Newbridge Financial Services Group's Idexx Laboratories position peaked at $118K in Q3 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.